Navigation Links
Is Earlier Detection of Cancers Such as Glioma Possible?
Date:5/21/2008

BOSTON, May 21 /PRNewswire/ -- Oncolab, Inc.'s AMAS(R) Test (http://www.oncolabinc.com) is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-specific antibody, the Anti-malignin antibody, in human serum.

Anti-malignin is a normal antibody in humans which has been found to increase with age, as the risk of cancer increases. During the early stages of cancer, Anti-malignin antibody increases markedly in concentration.

Determining the concentration of this antibody is the basis for the AMAS Test for early detection of cancer. This test was first used to aid in the diagnosis of brain cancer, and was then found to be applicable to other common cancers because the glioma peptide contains a structural characteristic that is shared by other malignant cells.

After early detection of cancers with the aid of the AMAS Test, additional diagnostic techniques can be employed to establish a diagnosis, and surgery or other standard therapeutic techniques can be employed to treat the malignancy. Oncolab, Inc., the company that has developed the AMAS Test, was recently granted additional patent claims covering advances in its antibody and antigen detection techniques, as well as potential vaccine applications of the technology.

Press Contact:

Kevin Walsh

kwalsh@oncolabinc.com

617-536-0850

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Oncolab, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis
2. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
3. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
4. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
5. Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
6. International Substance Detection Firm IDenta To Release New Lead Test Kit - Rash Of Toy Incidents Leads Company To Enter New Marketplace
7. iCAD, Inc. Awarded Two Additional Patents for Its Computer-Aided Detection Technology
8. The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
9. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
10. DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
11. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- On Thursday, March 23, 2017, the ... 0.07%; the Dow Jones Industrial Average edged 0.02% lower, ... at 2,345.96, marginally dropping 0.11%. US markets saw a ... sectors finished in red, and 1 sector ended flat ... coverage on the following Biotechnology equities: BioDelivery Sciences International ...
(Date:3/23/2017)... Research and Markets has announced the addition of ... offering. ... The Global Market for Bioproducts Should Reach $714.6 Billion ... of 8.9%, This research report quantifies the ... product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite ...
(Date:3/23/2017)... ... 23, 2017 , ... Ellen Matloff, president and CEO of ... as a 2017 Women of Innovation® finalist. Matloff will be among several women ... The dinner recognizes women accomplished in science, technology, engineering and math (STEM), along ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology:
(Date:3/22/2017)... 21, 2017 Vigilant Solutions , a ... enforcement agencies, announced today the appointment of retired FBI ... public safety business development. Mr. Sheridan brings ... including a focus on the aviation transportation sector, to ... position, Mr. Sheridan served as the Aviation Liaison Agent ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
Breaking Biology News(10 mins):